跳至主要内容
临床试验/NCT02134249
NCT02134249已完成2 期

Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome

Benha University2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2014年4月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
200
试验地点
2
主要终点
Number of participants with ovarian hyperstimulation syndrome (OHSS)

研究概览

简要总结

The purpose of this study is to compare the effect of oral Diosmin to oral Cabergoline in the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women underwent intracytoplasmic sperm injection (ICSI).

详细描述

Two hundred women at risk of ovarian hyperstimulation syndrome during ICSI cycles will be randomly scheduled into two equal groups. In group A, (Diosmin group), 2 tab / 8 hs Diosmin ( 500mg) will be given at day of HCG injection and for 2 weeks ; while in group B (Cabergoline group), 1 tab/day Cabergoline( 0.5 mg) will be given at day of HCG injection and for eight days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
23 Years 至 48 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • infertile women undergoing intracytoplasmic sperm injection or polycystic ovarin syndrome (PCO) with one of the following:
  • Presence of more than 20 follicles by ultrasound
  • E2 more than 3000 pg/ml
  • Retrieval of more than 15 follicles

排除标准

  • 未提供

研究组 & 干预措施

Group A (Diosmin group)

Active Comparator

In group A, (Diosmin group), 2 tab / 8 hs Diosmin ( 500mg) will be given from at day of HCG injection and for 14 days.

干预措施: Diosmin (Drug)

Group B(Cabergoline group)

Active Comparator

while in group B (Cabergoline group), 1 tab/day Cabergoline(Dostinex)( 0.5 mg) will be given at day of HCG injection and for 8 days .

干预措施: Cabergoline (Drug)

结局指标

主要结局

Number of participants with ovarian hyperstimulation syndrome (OHSS)

时间窗: every week for eight weeks

Diagnosis of OHSS was made according to the criteria of Golan et al.. Mild OHSS was classified as: Grade 1 (abdominal distension and discomfort) and Grade 2 (features of grade 1 plus nausea, vomiting and/or diarrhea; ovaries are enlarged from 5 to 12 cm), moderate OHSS as Grade 3 (features of mild OHSS plus ultrasonic evidence of ascites), severe OHSS as Grade 4 (features of moderate OHSS plus evidence of ascites and/or hydrothorax and breathing difficulties) and Grade 5 (all of the above, plus change in the blood volume, increased blood viscosity due to hemoconcentration, coagulation abnormality, and diminished renal perfusion and function).

次要结局

  • pregnancy rate(14 days after embryos transfer)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

khalid abd aziz mohamed

lecturer of ob/gyn

Benha University

研究点 (2)

Loading locations...

相似试验